Case study: Transitioning from insulin to glyburide in permanent neonatal diabetes: Medical and psychosocial challenges in an 18-year-old male

Clinical Diabetes

Volumn 27, Issue 1, 2009, Pages 25-29

  Monaghan, Maureen C ^d   Støy, Julie ^a   Streisand, Randi ^c   Philipson, Louis ^b   Cogen, Fran R ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; INSULIN GLARGINE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SITAGLIPTIN;

ADULT; ANXIETY; ARTICLE; ATHLETIC PERFORMANCE; BLOOD GLUCOSE MONITORING; CASE REPORT; CLINICAL RESEARCH; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; GENE MUTATION; GROWTH RETARDATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING DISORDER; MALE; MORNING DOSAGE; MOTOR PERFORMANCE; NEWBORN DISEASE; PATIENT COMPLIANCE; PATIENT MONITORING; PERMANENT NEONATE DIABETES MELLITUS; SALIVA ANALYSIS; SEIZURE; SIDE EFFECT; TREATMENT PLANNING; TREATMENT RESPONSE; WEIGHT REDUCTION; WRITING;

EID: 59349107957     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.27.1.25     Document Type: Article

References (11)

1. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JMCL, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JPH, Sumnik Z, van Rhijn A, Wales JKH, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849, 2004
2. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert J, Holst JJ, Clark PM, Ellard S, Sovik O, Polak M, Hattersley AT: Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467-477, 2006
3. Boden G, Chen X, Urbain JL: Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 45:1044-1050, 1996
4. von Muhlendahl KE, Herkenhoff H: Long-term course of neonatal diabetes. N Engl J Med 333:704-708, 1995
5. Malecki MT, Skupien J, Klupa T, Wanic K, Mlynarski W, Gach A, Solecka I, Sieradzki J: Transfer to sulfonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations. Diabetes Care 30:147-149, 2007
6. Landau Z, Wainstein J, Hanukoglu A, Tuval M, Lavie J, Glaser B: Sulfonylurea-responsive diabetes in childhood. J Pediatrics 150:553-555, 2007
7. Støy J, Greeley SAW, Paz VP, Ye H, Pastore AN, Skowron KB, Lipton RB, Cogen FR, Bell GI, Philipson LH, for the U.S. Neonatal Diabetes Working Group: Diagnosis and treatment of neonatal diabetes: the U.S. experience. Pediatr Diabetes 9:450-459, 2008
8. Triplitt C, Wright A, Chiquette E: Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus. Pharmacother 26:360-374, 2006
9. Brubaker PL: Incretin-based therapies: mimetics versus protease inhibitors. Trends Endocrinol Metab 18:240-245, 2007
10. Gloyn AL, Diatloff-Zito C, Edghill EL, Bellanne-Chantelot C, Nivot S, Coutant R, Ellard S, Hattersley AT, Robert JJ: KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. EurJ Human Genetics 14:824-830, 2006
11. Sligerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ: Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene. Diabetologia 49:2559-2563, 2006